Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. (Q50774403)

19 March 2018

title

Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. (English)

1 reference

19 March 2018

1 reference

Francisella tularensis

object named as

Francisella tularensis

1 reference

1 reference

4

Richard W Titball

1 reference

19 March 2018

author name string

Michael Green

series ordinal

1

1 reference

19 March 2018

Glyn Choules

series ordinal

2

1 reference

19 March 2018

Debbie Rogers

series ordinal

3

1 reference

19 March 2018

language of work or name

English

0 references

publication date

1 April 2005

1 reference

19 March 2018

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

19 March 2018

volume

23

1 reference

19 March 2018

issue

20

1 reference

19 March 2018

page(s)

2680-2686

1 reference

19 March 2018

Francisella tularensis: host-parasite interaction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

7 January 2021

The tularaemia vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Studies on the immunogenic properties of bacterium tularense variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

LIVE TULAREMIA VACCINE I. : Host-Parasite Relationship in Monkeys Vaccinated Intracutaneously or Aerogenically

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

7 January 2021

inferred from DOI database lookup

Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

7 January 2021

inferred from DOI database lookup

Live vaccine strain of Francisella tularensis: infection and immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.071

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2004.03.071

1 reference

19 March 2018

PubMed ID

15780452

1 reference

19 March 2018